Related Experiment Video
Updated: Aug 23, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Evidence-based treatment of lipids in the elderly
1Department of Medicine/Division of Cardiology, Feinberg School of Medicine, Northwestern University, 211 E. Chicago Avenue, Chicago, IL 60611, USA.
Insights
Statins effectively reduce atherosclerotic cardiovascular disease risks in the elderly. This review highlights their benefits, risks, and the importance of clinical judgment for statin therapy in older adults.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Elderly individuals face high risks of atherosclerotic cardiovascular disease (ASCVD) morbidity and mortality.
- Statins are proven to reduce ASCVD events in middle-aged and elderly populations.
- Older adults represent a significant cohort in major statin trials.
Purpose of the Study:
- To review major statin trials focusing on elderly subjects.
- To analyze the positive and negative impacts of statins in the elderly population.
- To discuss risk assessment and clinical judgment for statin use in older adults.
Main Methods:
- Review of large-scale statin clinical trials.
- Emphasis on data from elderly participants.
- Tabulation of statin effects (positive and negative) in older individuals.
Main Results:
- Statins demonstrate efficacy in reducing ASCVD events in the elderly.
- The review tabulates both benefits and adverse effects of statins in this demographic.
- Clinical judgment is crucial for selecting elderly patients for statin therapy.
Conclusions:
- Statins offer significant benefits for ASCVD risk reduction in the elderly.
- Careful consideration of risks, costs, and individual patient factors is essential.
- Risk assessment, including subclinical atherosclerosis, guides statin therapy decisions in older adults.
Abstract:
The elderly (men aged 65 years and older and women aged 75 years and older) constitute a population at high absolute risk for the morbidity and mortality of atherosclerotic cardiovascular disease. Statins have been shown in multiple large trials to reduce the burden of atherosclerotic disease in both middle-aged and elderly patients at elevated risk for coronary events, stroke, and death. We reviewed the major statin trials with particular emphasis on the significant number of elderly subjects. The impact of statins on the elderly, both positive and negative, is tabulated. In addition, we briefly discuss risk assessment in the elderly because selection of elderly patients for intensive low-density lipoprotein cholesterol reduction with statins requires clinical judgment that must weigh the need for subclinical measures of atherosclerosis. We also consider negative aspects, risks, and costs of such therapy.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Angina IV: Management